Melbourne biotech PolyActiva scores $27m NRFC investment

June 2nd, 2025

InnovationAus, Other, 30/05/2025, James Riley
Melbourne-based biotech firm PolyActiva which has spent 15 years developing an eye-implant technology to treat glaucoma, has won a $27 million investment from the National Reconstruction Fund Corporation as part of a $40 million Series C round. […] PolyActiva was founded in 2010 to commercialise Prezia technology that emerged from the CSIRO, Bionics Institute and Centre for Eye Research Australia.